160 related articles for article (PubMed ID: 33498721)
21. GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma.
Liu T; Kan XF; Ma C; Chen LL; Cheng TT; Zou ZW; Li Y; Cao FJ; Zhang WJ; Yao J; Li PD
Tumour Biol; 2017 Jun; 39(6):1010428317700410. PubMed ID: 28635398
[TBL] [Abstract][Full Text] [Related]
22. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
Lin YH; Wu MH; Huang YH; Yeh CT; Cheng ML; Chi HC; Tsai CY; Chung IH; Chen CY; Lin KH
Hepatology; 2018 Jan; 67(1):188-203. PubMed ID: 28802060
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA 0016788 displays as a biomarker for tumor progression and poor prognosis in surgical hepatocellular carcinoma patients.
Cheng F; Wang L; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23300. PubMed ID: 32319701
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
Cao C; Wang C
Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
[TBL] [Abstract][Full Text] [Related]
25. Malic enzyme 1 induces epithelial-mesenchymal transition and indicates poor prognosis in hepatocellular carcinoma.
Wen D; Liu D; Tang J; Dong L; Liu Y; Tao Z; Wan J; Gao D; Wang L; Sun H; Fan J; Wu W
Tumour Biol; 2015 Aug; 36(8):6211-21. PubMed ID: 25753478
[TBL] [Abstract][Full Text] [Related]
26. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma.
Xu QG; Yuan SX; Tao QF; Yu J; Cai J; Yang Y; Guo XG; Lin KY; Ma JZ; Dai DS; Wang ZG; Gu FM; Zhao LH; Li LQ; Liu JF; Sun SH; Zang YJ; Liu H; Yang F; Zhou WP
J Hepatol; 2019 May; 70(5):904-917. PubMed ID: 30654066
[TBL] [Abstract][Full Text] [Related]
27. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
28. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
29. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study.
Wu MY; Kuo CS; Lin CY; Lu CL; Syu Huang RF
Br J Nutr; 2009 Sep; 102(5):715-21. PubMed ID: 19331700
[TBL] [Abstract][Full Text] [Related]
30. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
31. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
32. Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma.
Huang R; Yan G; Sun H; Zhang J; Song D; Kong R; Yan P; Hu P; Xie A; Wang S; Zhuang J; Yin H; Meng T; Huang Z
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32627826
[TBL] [Abstract][Full Text] [Related]
33. High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma.
Liao W; Huang G; Liao Y; Yang J; Chen Q; Xiao S; Jin J; He S; Wang C
Oncotarget; 2014 Nov; 5(21):10271-9. PubMed ID: 25431949
[TBL] [Abstract][Full Text] [Related]
34. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
[TBL] [Abstract][Full Text] [Related]
35. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
[TBL] [Abstract][Full Text] [Related]
36. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.
Yamada S; Nomoto S; Fujii T; Kaneko T; Takeda S; Inoue S; Kanazumi N; Nakao A
Eur J Surg Oncol; 2006 Apr; 32(3):303-7. PubMed ID: 16478656
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
[TBL] [Abstract][Full Text] [Related]
39. TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma.
Lin YH; Wu MH; Huang YH; Yeh CT; Lin KH
Cells; 2020 Jan; 9(2):. PubMed ID: 31973032
[TBL] [Abstract][Full Text] [Related]
40. Relationship between the expression of MDR1 in hepatocellular cancer and its biological behaviors.
Gao B; Yang FM; Yu ZT; Li R; Xie F; Chen J; Luo HJ; Zhang JC
Int J Clin Exp Pathol; 2015; 8(6):6995-7001. PubMed ID: 26261589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]